Table 2 Relapse rates requiring and not requiring hospitalization
Medication | Compliant (%) | Partial compliant (%) | Non-compliant (%) | Source |
|---|---|---|---|---|
Relapse rates requiring hospitalizations | ||||
 Olanzapine | 2 | 4 | 5 | Ascher-Svanum et al. (US study) [22] |
 Risperidone | 4 | 6 | 9 | |
 Aripiprazole | 5 | 9 | 12 | |
 ODT olanzapine | 2 | 4 | 5 | |
 ODT risperidone | 4 | 6 | 9 | |
 ODT aripiprazole | 5 | 9 | 12 | |
Relapse rates not requiring hospitalizations | ||||
 Olanzapine | 2 | 3 | 5 | Ascher-Svanum et al. (US study) [22] |
 Risperidone | 4 | 6 | 9 | |
 Aripiprazole | 5 | 8 | 11 | |
 ODT olanzapine | 2 | 3 | 5 | |
 ODT risperidone | 4 | 6 | 9 | |
 ODT aripiprazole | 5 | 8 | 11 | |